Givaudan SA (OTCMKTS:GVDNY - Get Free Report) hit a new 52-week low during mid-day trading on Wednesday . The company traded as low as $69.93 and last traded at $71.11, with a volume of 7894 shares changing hands. The stock had previously closed at $71.3130.
Wall Street Analysts Forecast Growth
A number of brokerages have recently weighed in on GVDNY. Deutsche Bank Aktiengesellschaft reissued a "buy" rating on shares of Givaudan in a research report on Friday, January 30th. Citigroup reiterated a "neutral" rating on shares of Givaudan in a report on Tuesday, February 3rd. Finally, The Goldman Sachs Group cut shares of Givaudan from a "strong-buy" rating to a "sell" rating in a report on Tuesday, February 10th. One analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy".
View Our Latest Stock Report on GVDNY
Givaudan Price Performance
The business has a fifty day moving average price of $77.91 and a 200-day moving average price of $81.20. The company has a current ratio of 1.74, a quick ratio of 1.13 and a debt-to-equity ratio of 0.92.
Givaudan Company Profile
(
Get Free Report)
Givaudan is a Swiss-based global company that develops, manufactures and supplies flavors, fragrances and active cosmetic ingredients for a broad range of consumer products. The company's core activities are organized around creating taste and scent solutions—ranging from fine fragrances and consumer-packaged goods scents to flavor systems for food and beverages and functional ingredients for personal care. Givaudan works with brand owners and manufacturers to design sensory experiences, improve product performance and meet formulation or regulatory requirements.
Its product and service offerings include bespoke fragrance creation, flavor formulation, natural ingredient sourcing, aroma chemicals, taste modulators and application support such as prototyping and sensory testing.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Givaudan, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Givaudan wasn't on the list.
While Givaudan currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.